Product Code: SR112025A6915
The global jet lag therapy market size reached USD 441.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 619.3 Million by 2033, exhibiting a growth rate (CAGR) of 3.73% during 2025-2033. The rising number of international travelers experiencing sleep disruptions is raising the demand for effective therapies, thereby stimulating the market.
Jet lag is a temporary sleep disorder that occurs after traveling in different time zones. It is associated with fatigue, insomnia, difficulty adjusting to the local time, confusion, headache, and digestive problems, such as constipation or diarrhea. It can be treated using medications and light and melatonin therapies. These therapies help in reducing the symptoms of jet lag, improving sleep quality, increasing productivity, boosting mood, and minimizing the risk of jet lag-related accidents. Jet lag therapy also helps the internal clock of the body adjust more quickly to the new time zone and allows individuals to return to their regular routine more quickly. At present, various companies are developing personalized jet lag therapy plans that use data like travel history to meet the requirements of an individual.
Jet Lag Therapy Market Trends:
The increasing air travel activities by individuals for business, leisure, and other purposes on account of rapid urbanization and inflating income levels represent one of the major factors driving the demand for jet lag therapy around the world. Moreover, the rising aging population, which is more prone to jet lag, is favoring the market growth. Besides this, the increasing awareness about jet lag, its symptoms, and the easy availability of the treatments like jet lag therapy is bolstering the growth of the market. In addition, the easy availability of various non-pharmacological therapies for alleviating the symptoms associated with jet lag, such as acupuncture, yoga, and massage, is favoring the market growth. Apart from this, the growing adoption of wearable devices, including smartwatches and fitness trackers, to track sleep patterns and monitor the internal clock of the body is influencing the market positively. Furthermore, there is a rise in the integration of virtual reality (VR) and artificial intelligence (AI) to mimic exposure to natural light, analyze data from wearable devices, and provide real time recommendations and adjustments. This, coupled with the advent of mobile applications that help provide information and support jet lag therapy by offering data about light exposure and sleep hygiene, is propelling the growth of the market. Additionally, extensive research and development (R&D) activities for introducing novel therapies and medications are anticipated to create a positive outlook for the market.
Key Market Segmentation:
Product Insights:
- Prescription Drugs
- Provigil/Nuvigil
- Ambien
- Lunesta
- Sonata
- Others
- Melatonin
- Herbal and Natural Products
- Medical Devices
- Light Box
- Wearable Devices
- Others
Application Insights:
- Business Travelers
- Cabin Crew
- Athletes
- Seasonal Travelers
- Others
Distribution Channel Insights:
End Users Insights:
- Hospitals
- Homecare
- Speciality Clinics
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for jet lag therapy. Some of the factors driving the North America jet lag therapy market included the increasing air travelers, rising healthcare industry, and growing awareness about jet lag and its therapy among individuals.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global tea market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered Chrono Eyewear B.V., Clinigen Limited, Jamieson Wellness Inc., Lucimed SA, Lumie, Nature Bright, Nature's Bounty Inc. (Nestle S.A.), Northern Light Technologies, Re-Timer Pty Ltd., Verilux Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global jet lag therapy market performed so far, and how will it perform in the coming years ?
- What are the drivers, restraints, and opportunities in the global jet lag therapy market ?
- What is the impact of each driver, restraint, and opportunity on the global jet lag therapy market growth ?
- What are the key regional markets ?
- Which countries represent the most attractive jet lag therapy markets ?
- What is the breakup of the market based on the product ?
- Which is the most attractive product in the jet lag therapy market ?
- What is the breakup of the market based on the application ?
- Which is the most attractive application in the jet lag therapy market ?
- What is the breakup of the market based on the distribution channel ?
- Which is the most attractive distribution channel in the jet lag therapy market ?
- What is the breakup of the market based on the end user ?
- Which is the most attractive end user in the jet lag therapy market ?
- What is the competitive structure of the global jet lag therapy market ?
- Who are the key players/companies in the global jet lag therapy market ?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Jet Lag Therapy Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Prescription Drugs
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Provigil/Nuvigil
- 6.1.2.2 Ambien
- 6.1.2.3 Lunesta
- 6.1.2.4 Sonata
- 6.1.2.5 Others
- 6.1.3 Market Forecast
- 6.2 Melatonin
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Herbal and Natural Products
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Medical Devices
- 6.4.1 Market Trends
- 6.4.2 Key Segments
- 6.4.2.1 Light Box
- 6.4.2.2 Wearable Devices
- 6.4.3 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Business Travelers
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cabin Crew
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Athletes
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Seasonal Travelers
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Over the Counter
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Online
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Homecare
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Specialty Clinics
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Chrono Eyewear B.V.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Clinigen Limited
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Jamieson Wellness Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Lucimed SA
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Lumie
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Nature Bright
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Nature's Bounty Inc. (Nestle S.A.)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 SWOT Analysis
- 15.3.8 Northern Light Technologies
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Re-Timer Pty Ltd.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Verilux Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.